New SEC Form D filing
Trace Biosciences Inc., 2026-08-12
A new SEC Form D private-offering notice from Beaverton, OR, a $16,234,498 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Developer of a nerve specific fluorescence imaging agent that helps surgeons visualize nerves in real time during surgery
Filed 7 days agoFiled to raise $16,234,498First money in 2026-07-28Raised so far $8,334,499HQ (as filed) Beaverton, ORSector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified trace-bio.com↗Named in the filing 4 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- BBMW Holdings LLC, 2026-08-13, $4.5M, Beaverton, OR
- HYKU BIOSCIENCES INC., 2026-08-13, $8.6M, Concord, MA
- Wildfire Water Solutions, Inc., 2026-07-30, $8M, Bend, OR
- Auron Therapeutics, Inc., 2026-08-13, $12M, Wellesley, MA
- Compounding Collective LLC, 2026-07-20, $1.5M, Clackamas, OR
- Abcuro, Inc., 2026-08-13, $176.5M, Newton, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.